Evidence map›Paper›PMID 37840931›Full record

SynthesisFrontiers in neurology2023

Prevalence of cerebral palsy comorbidities in China: a systematic review and meta-analysis.

Chao Gong, Xiaopei Liu, Liya Fang, Annan Liu, Beibei Lian, Xunzhong Qi, Shuyue Chen, Huiqing Li, Ming Zhao, Jin Guo and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Chao GongCollege of Rehabilitation Medicine, Jiamusi University, Jiamusi, China.
Xiaopei LiuCollege of Rehabilitation Medicine, Jiamusi University, Jiamusi, China.
Liya FangCollege of Rehabilitation Medicine, Jiamusi University, Jiamusi, China.
Annan LiuCollege of Rehabilitation Medicine, Jiamusi University, Jiamusi, China.
Beibei LianCollege of Rehabilitation Medicine, Jiamusi University, Jiamusi, China.
Xunzhong QiJiamusi University Affiliated No. 1 Hospital, Jiamusi, China.
Shuyue ChenCollege of Basic Medicine, Jiamusi University, Jiamusi, China.
Huiqing LiCollege of Basic Medicine, Jiamusi University, Jiamusi, China.
Ming ZhaoCollege of Public Health, Jiamusi University, Jiamusi, China.
Jin GuoCollege of Rehabilitation Medicine, Jiamusi University, Jiamusi, China.
Shaobo ZhouSchool of Science, Faculty of Engineering and Science, University of Greenwich, Medway Campus Central Avenue, Chatham Maritime, Kent, England.
Jiamusi University · CNCalifornia Maritime Academy · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This systematic review aimed to comprehensively understand the comorbidity of cerebral palsy (CP) in China. Methods: We searched through databases in both Chinese and English until December 2022 to gather cross-sectional studies on the comorbidity of CP in China. After two reviewers independently screened the articles, collected the data, and assessed the bias risk, a meta-analysis was conducted using the Stata 17.0 software. Results: A total of 73 articles were included. Of these, 16 articles reported total comorbidity, with a prevalence of 79.7% (95% CI: 73.8-85.7%); 56 articles reported epilepsy, with a prevalence of 17.9% (95% CI: 15.4-20.4%); 48 articles reported intellectual disability, with a prevalence of 58.0% (95% CI: 51.8-64.3%); 32 articles reported speech disorders, with a prevalence of 48.0% (95% CI: 41.6-54.4%); 41 articles reported hearing disorders, with a prevalence of 17.2% (95% CI: 13.0-21.4%); and 35 articles reported vision disorders, with a prevalence of 23.1% (95% CI: 16.3-29.8%). The topographical type of CP was the primary source of heterogeneity in the prevalence of epilepsy. Diagnostic criteria for CP, clinical type of CP, GMFCS, publishing time, and topographical type of CP were the primary sources of heterogeneity in the prevalence of intellectual disability. Clinical type of CP and topographical type were the primary sources of heterogeneity in the prevalence of speech disorders. Finally, the region was the primary source of heterogeneity in the prevalence of hearing disorders. Conclusion: The prevalence of comorbidities in CP is high in China. Comorbidities are related to the characteristics, severity, and risk factors of brain insult and have a particular relationship with regional economic development and medical and health levels.

Indexed as

cerebral palsyChinacomorbiditiesepilepsymeta-analyzesprevalence

Identifiers

PMID37840931
PMCPMC10568468
OpenAlexW4387305032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.